Clinical Pharmacology Principles Flashcards
Affinity
Shape of linear [drug] proportion of receptor bound graph
Shape of semilog graph [drug] proportion of receptors bound graph
What happens when you add a competitive antagonist
Measure of how well a drug binds to the receptor
Bind at a rate proportional to the [drug]
Unbind at a rate that depends on the chemical properties of the drug-receptor complex
Linear - rapid increase which plateaus
Semilog - sigmoid
Right shift
Agonists and antagonists
-how do they work
Types of antagonists
Agonists - binds to target to increase activity
Antagonists - opposes action of another chemical
-cannot act without an agonist (can vary with physiological states
Competitive - prevents direct binding of agonist => right shift
Non-competitive - indirectly prevents binding of agonist
Affinity vs efficacy
-how do they affect the dose?
Affinity - tendency for molecule to bind to receptor
Efficacy - how well an agonist achieves a response
Different drugs acting at the same targets can have different efficacies
Different doses needed to achieve same effect
With non-competitive antagonists, affinity of agonist does not change but efficacy does
Potency of a drug
Shape of graph with
-full agonists
-partial agonists
EC50 - [drug] that elicits 50% of the maximal response
Lower EC50 = higher potency at lower conc
Have the same shape (linear andc log) but partial agonists do not reach the full effect of 1 (Emax)
Allosteric modulators
-how do they work
Bind to a site that is not the primary binding site to
-alter affinity of binding site to agonist
-change efficacy of response when agonist binds
This change can be positive or negative
Desensitisation
Continued use => reduced number of receptors
-development of tolerance
Nicotinic receptor
-location
Skeletal muscle
Autonomic neurones in CNS
-presynaptic nerve terminals
-postganglionic sympathetic neurones
How do [drug] differ in different body compartments
-how does this affect their effects
Lipophilic
Hydrophilic
These properties depends on the chemical structure
Affect metabolism, excretion
Monoamines
-what are they
-how is their action terminated, and the clinical relevance of this
NA, D, 5HT (seretonin)
Reuptake through presynaptic nerve terminal
-SSRI, SNRI, TCAs, COC, AMP, MDMA affects reuptake
Antidepressants have a smaller potential for abuse because of the limited affect on D reuptake receptors
Enzyme drug interactions
-types of inhibition
Competitive
Non competitive
Reversible
Irreversible - causing permanent loss of function until more enzyme is synthesised